01 1Guerbet LLC
02 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
03 1SpecGx LLC
01 3Ioversol
01 1China
02 1France
03 1Ireland
NDC Package Code : 67684-8777
Start Marketing Date : 2018-09-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57884-0015
Start Marketing Date : 2019-09-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-7888
Start Marketing Date : 2014-05-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ioversol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ioversol, including repackagers and relabelers. The FDA regulates Ioversol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ioversol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ioversol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ioversol supplier is an individual or a company that provides Ioversol active pharmaceutical ingredient (API) or Ioversol finished formulations upon request. The Ioversol suppliers may include Ioversol API manufacturers, exporters, distributors and traders.
click here to find a list of Ioversol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ioversol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ioversol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ioversol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ioversol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ioversol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ioversol suppliers with NDC on PharmaCompass.
We have 3 companies offering Ioversol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
